BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 34858707)

  • 1. One-dimensional scanning multiphoton imaging reveals prolonged calcium transient and sarcomere contraction in a zebrafish model of doxorubicin cardiotoxicity.
    Chao YK; Liau I
    Biomed Opt Express; 2021 Nov; 12(11):7162-7172. PubMed ID: 34858707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel compound DT-010 protects against doxorubicin-induced cardiotoxicity in zebrafish and H9c2 cells by inhibiting reactive oxygen species-mediated apoptotic and autophagic pathways.
    Tang F; Zhou X; Wang L; Shan L; Li C; Zhou H; Lee SM; Hoi MP
    Eur J Pharmacol; 2018 Feb; 820():86-96. PubMed ID: 29229534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longitudinal and quantitative assessment platform for concurrent analysis of anti-tumor efficacy and cardiotoxicity of nano-formulated medication in vivo.
    Tu WM; Huang XC; Chen YL; Luo YL; Liau I; Hsu HY
    Anal Chim Acta; 2020 Jan; 1095():129-137. PubMed ID: 31864613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative study on beneficial effects of vitamins B and D in attenuating doxorubicin induced cardiotoxicity in rats: Emphasis on calcium homeostasis.
    Awad HH; El-Derany MO; Mantawy EM; Michel HE; El-Naa MM; Salah El-Din RA; El-Brairy AI; El-Demerdash E
    Biomed Pharmacother; 2021 Aug; 140():111679. PubMed ID: 34029952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salvianolic acid B attenuates doxorubicin-induced ER stress by inhibiting TRPC3 and TRPC6 mediated Ca
    Chen RC; Sun GB; Ye JX; Wang J; Zhang MD; Sun XB
    Toxicol Lett; 2017 Jul; 276():21-30. PubMed ID: 28495616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of CACNA1H attenuates doxorubicin-induced acute cardiotoxicity by affecting endoplasmic reticulum stress.
    Hu J; Wu Q; Wang Z; Hong J; Chen R; Li B; Hu Z; Hu X; Zhang M
    Biomed Pharmacother; 2019 Dec; 120():109475. PubMed ID: 31580970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alternative approach for mitigation of doxorubicin-induced cardiotoxicity using herbal agents.
    Khan MA; Singh M; Khan MS; Ahmad W; Najmi AK; Ahmad S
    Curr Clin Pharmacol; 2014; 9(3):288-97. PubMed ID: 23342982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitophagy inhibitor liensinine suppresses doxorubicin-induced cardiotoxicity through inhibition of Drp1-mediated maladaptive mitochondrial fission.
    Liang X; Wang S; Wang L; Ceylan AF; Ren J; Zhang Y
    Pharmacol Res; 2020 Jul; 157():104846. PubMed ID: 32339784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasmatic and chamber-specific modulation of cardiac microRNAs in an acute model of DOX-induced cardiotoxicity.
    Gioffré S; Ricci V; Vavassori C; Ruggeri C; Chiesa M; Alfieri I; Zorzan S; Buzzetti M; Milano G; Scopece A; Castiglioni L; Sironi L; Pompilio G; Colombo GI; D'Alessandra Y
    Biomed Pharmacother; 2019 Feb; 110():1-8. PubMed ID: 30453253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. S100A8 and S100A9 Are Associated with Doxorubicin-Induced Cardiotoxicity in the Heart of Diabetic Mice.
    Pei XM; Tam BT; Sin TK; Wang FF; Yung BY; Chan LW; Wong CS; Ying M; Lai CW; Siu PM
    Front Physiol; 2016; 7():334. PubMed ID: 27547188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of Carbonyl Reductase 1 Safely Improves the Efficacy of Doxorubicin in Breast Cancer Treatment.
    Jo A; Choi TG; Jo YH; Jyothi KR; Nguyen MN; Kim JH; Lim S; Shahid M; Akter S; Lee S; Lee KH; Kim W; Cho H; Lee J; Shokat KM; Yoon KS; Kang I; Ha J; Kim SS
    Antioxid Redox Signal; 2017 Jan; 26(2):70-83. PubMed ID: 27357096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Novel Danshensu Derivative Prevents Cardiac Dysfunction and Improves the Chemotherapeutic Efficacy of Doxorubicin in Breast Cancer Cells.
    Wang L; Zhang X; Chan JY; Shan L; Cui G; Cui Q; Wang Y; Li J; Chen H; Zhang Q; Yu P; Han Y; Wang Y; Lee SM
    J Cell Biochem; 2016 Jan; 117(1):94-105. PubMed ID: 26058377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Creatine kinase-overexpression improves myocardial energetics, contractile dysfunction and survival in murine doxorubicin cardiotoxicity.
    Gupta A; Rohlfsen C; Leppo MK; Chacko VP; Wang Y; Steenbergen C; Weiss RG
    PLoS One; 2013; 8(10):e74675. PubMed ID: 24098344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel agent attenuates cardiotoxicity and improves antitumor activity of doxorubicin in breast cancer cells.
    Zhang Y; Deng H; Zhou H; Lu Y; Shan L; Lee SM; Cui G
    J Cell Biochem; 2019 Apr; 120(4):5913-5922. PubMed ID: 30304553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nicotinamide riboside promotes autolysosome clearance in preventing doxorubicin-induced cardiotoxicity.
    Zheng D; Zhang Y; Zheng M; Cao T; Wang G; Zhang L; Ni R; Brockman J; Zhong H; Fan GC; Peng T
    Clin Sci (Lond); 2019 Jul; 133(13):1505-1521. PubMed ID: 31266854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Edaravone and benidipine protect myocardial damage by regulating mitochondrial stress, apoptosis signalling and cardiac biomarkers against doxorubicin-induced cardiotoxicity.
    Hassan MQ; Akhtar MS; Afzal O; Hussain I; Akhtar M; Haque SE; Najmi AK
    Clin Exp Hypertens; 2020 Jul; 42(5):381-392. PubMed ID: 31630586
    [No Abstract]   [Full Text] [Related]  

  • 17. Neonatal murine engineered cardiac tissue toxicology model: Impact of dexrazoxane on doxorubicin induced injury.
    Zhen J; Yu H; Ji H; Cai L; Leng J; Keller BB
    Life Sci; 2019 Dec; 239():117070. PubMed ID: 31751580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigallocatechin-3-gallate pretreatment attenuates doxorubicin-induced cardiotoxicity in rats: A mechanistic study.
    Saeed NM; El-Naga RN; El-Bakly WM; Abdel-Rahman HM; Salah ElDin RA; El-Demerdash E
    Biochem Pharmacol; 2015 Jun; 95(3):145-55. PubMed ID: 25701654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. (-)-Epigallocatechin-3-gallate alleviates doxorubicin-induced cardiotoxicity in sarcoma 180 tumor-bearing mice.
    Yao YF; Liu X; Li WJ; Shi ZW; Yan YX; Wang LF; Chen M; Xie MY
    Life Sci; 2017 Jul; 180():151-159. PubMed ID: 27956351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CaMKII activation participates in doxorubicin cardiotoxicity and is attenuated by moderate GRP78 overexpression.
    Tscheschner H; Meinhardt E; Schlegel P; Jungmann A; Lehmann LH; Müller OJ; Most P; Katus HA; Raake PW
    PLoS One; 2019; 14(4):e0215992. PubMed ID: 31034488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.